Marsh & McLennan Companies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRSH research report →
Range $182 – $234
Price Chart
About the company
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals.
- CEO
- John Q. Doyle
- IPO
- 1987
- Employees
- 95,000
- HQ
- New York City, NY, US
AI snapshot
Six angles, distilled from the data.
The stock is still in a corrective regime, trading below both the 200-day moving average of 177.73 and the 50-day of 185.51. It remains well off the 52-week high of 204.56, though still above the 52-week low of 155.72, which keeps the long-term trend constructive but not fully repaired.
Street sentiment is cautious-to-neutral: the consensus is Hold, with 3 Buys, 13 Holds, and 1 Sell. The average target sits at 203.43, above the last close, and recent action has been mostly target raises alongside one downgrade from Buy to Neutral, signaling upside but limited conviction.
The earnings cadence is strong, with 7 straight EPS beats and the next report due 2026-10-15. Estimates still point higher, with 2026 EPS at 10.448 versus 2025 EPS of 9.60062 and 2027 EPS at 11.4041. Shareholders should watch whether the beat streak and margin discipline hold.
Recent insider activity leans negative on the headline, driven by discretionary selling from the CEO and General Counsel. Most of the other filings are awards or other non-discretionary transfers, which are noise rather than a conviction signal.
Profitability remains solid, with a 26.32% operating margin and 14.24% net margin. Growth is steady rather than explosive, with revenue up 6.2% year over year and EPS up 7.3%, while free cash flow of $5.58 billion supports the business.
As an insurance broker, MRSH wins on scale, recurring advisory demand, and high returns, including 25.9% ROE. The valuation is not cheap but not stretched either, at 17.04x earnings versus a consensus target that still sits above the current share price.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $81.66B
- P/E
- 20.84
- Fwd P/E
- 16.38
- PEG
- -9.72
- P/S
- 2.92
- P/B
- 5.43
- EV/EBITDA
- 17.78
- Div Yield
- 2.10%
- Gross Margin
- 42.38%
- Op Margin
- 21.62%
- Net Margin
- 14.24%
- ROE
- 26.53%
- ROIC
- 11.40%
Latest fiscal year · YoY change
- Revenue
- $26.98B+10.3%
- Gross Profit
- $11.40B+9.0%
- Op Income
- $6.22B
- Net Income
- $4.16B+2.5%
- EPS
- $8.48+2.8%
- OCF Growth
- +23.0%
- FCF Growth
- +25.5%
- 52W High
- $207.83
- 52W Low
- $156.60
- 50D MA
- $184.78
- 200D MA
- $177.49
- Beta
- 0.58
- RSI (14)
- 33
- Avg Volume
- 2.46M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Marsh posted solid Q2 2026 results with 6% revenue growth, 9% adjusted EPS growth, and continued margin expansion despite pricing pressure in reinsurance and softer insurance market rates.· July 21, 2026
- Revenue rose 6% to $7.4 billion; adjusted EPS was $2.96, up 9% year over year.
- Underlying revenue growth accelerated to 5% from 4% in the prior quarter, with strength in Consulting and Marsh Risk.
- Guy Carpenter was the weak spot: revenue fell 2%, hit by the steepest property cat rate decline in the index’s 25-year history.
- Management reiterated full-year 2026 expectations for underlying growth similar to 2025, another year of margin expansion, and solid adjusted EPS growth.
- Capital deployment guidance increased to about $5.5 billion for 2026, and the quarterly dividend was raised 10%.
Consolidated revenue increased 6% year over year to $7.4 billion, or 5% on an underlying basis. Adjusted operating income grew 5% to $2.2 billion, with an adjusted operating margin of 29.3%; GAAP EPS was $2.63 and adjusted EPS was $2.96, up 9% year over year. For the first six months of 2026, adjusted operating income increased 7% to $4.6 billion, adjusted operating margin was 30.5%, and adjusted EPS rose 8% to $6.25. Segment results included Marsh Risk revenue of $4.1 billion, up 6% reported and 4% underlying; Guy Carpenter revenue of $664 million, down 2%; Mercer revenue of $1.6 billion, up 7% reported and 5% underlying; and Marsh Management Consulting revenue of $1.0 billion, up 15% reported and 13% underlying. Looking ahead, management expects 2026 underlying revenue growth similar to 2025, another year of margin expansion, and solid adjusted EPS growth; for Q3 they expect fiduciary interest income of about $95 million, adjusted corporate expense of about $75 million, similar interest expense to Q2, and Marsh Management Consulting underlying growth in the mid- to high single digits. The 2026 adjusted effective tax rate is expected to be 24.5% to 25.5%, and capital deployment is now expected to be about $5.5 billion, up from $5 billion previously.
John Doyle said Marsh had a solid quarter with demand for its advice and capabilities remaining strong, and he emphasized that underlying growth accelerated and the company is executing well despite pricing headwinds. Strategically, he focused on Thrive, unified branding across Marsh/Guy Carpenter/Mercer, expanding sales capacity, and using AI to drive growth, productivity, and efficiency. His tone was confident and upbeat, but he repeatedly acknowledged a softer pricing environment and broader economic/geopolitical uncertainty.
Mark McGivney highlighted continued execution and diversification, with consolidated revenue up 6% to $7.4 billion and adjusted operating margin at 29.3%; first-half adjusted operating income rose 7% to $4.6 billion and adjusted EPS rose 8% to $6.25. He detailed segment margins, including RIS at 35.3% and Consulting at 20.5%, and said Thrive remains on track to deliver $400 million of total savings, with about $500 million of charges expected to generate those savings. On capital allocation, he noted $1.7 billion of cash, $20.6 billion of total debt, $1.4 billion of cash uses in Q2, and a revised expectation to deploy about $5.5 billion in 2026 across dividends, acquisitions, and buybacks; he also cited the 10% dividend increase and said the next debt maturity is $550 million of euro notes due in Q3 and expected to be refinanced.
Analysts focused on whether Marsh Risk growth can offset pricing pressure, especially in Guy Carpenter, and management answered that strong new business, improved U.S. production hiring, and broad international momentum are helping cushion rate declines. They also pressed on AI investment costs and producer headcount; management said it is using lower-cost internal tools like LenWork while supplementing with frontier models where needed, and that producer hiring has been a good first-half growth driver but is not the only lever. Other questions centered on M&A, consulting momentum, and health growth, with management saying M&A remains disciplined amid bid-ask gaps, consulting growth was broad-based rather than one-time-driven, and Mercer health slowed to 3% in the quarter mainly due to ordinary retention and tougher employer conditions rather than a structural issue.
The quarter showed broad-based growth outside reinsurance, with Marsh Risk, Mercer, and Consulting all contributing and Management citing strong new business, especially in the U.S. and internationally. Management sounded confident that Thrive, brand unification, AI tools, and continued talent investment can support both growth and margin expansion over time.
Guy Carpenter remains under pressure from falling reinsurance pricing, especially property cat rates, and management said market consolidation also hurt growth. The call also acknowledged a softer environment in parts of international consulting, ongoing uncertainty around M&A close rates, and rising technology costs that could offset some AI-driven efficiency gains if not managed well.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.9%
- Shares Outstanding
- 477.21M
- Float Shares
- 476.72M
of shares held by institutions
1,580 13F filers
Buy/sell ratio 1.75. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for MRSH, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Kevin HernHouse · OK01 | Sell | Aug 24, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jun 2, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 1, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Apr 13, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 13, 26 | Filing → |
| Tina SmithSenate · MN | Sell | Jan 27, 26 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 39.50M | ▼ 2.56M |
| Vanguard Capital Management LLC | 31.47M | ▲ 4.90K |
| State Street Corp | 22.40M | ▲ 330.73K |
| Capital World Investors | 18.12M | ▲ 153.16K |
| Wellington Management Group Llp | 16.98M | ▼ 395.47K |
| Capital International Investors | 15.73M | ▲ 15.60K |
| Geode Capital Management, LLC | 13.51M | ▲ 106.10K |
| Price T Rowe Associates Inc | 13.44M | ▲ 2.46M |
| Vanguard Portfolio Management LLC | 12.57M | ▲ 142.57K |
| Capital Research Global Investors | 10.97M | ▼ 327.54K |
| Harris Associates L P | 8.69M | ▲ 3.52M |
| Artisan Partners Limited Partnership | 7.27M | ▲ 2.39M |
Held by 1,576 ETFs
Biggest fund positions in MRSH by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 2, 26 | Brennan Katherine | other | 1,197 |
| Sep 2, 26 | Brennan Katherine | sell | 1,197 |
| Sep 2, 26 | Brennan Katherine | other | 1,197 |
| Sep 2, 26 | Doyle John Q | other | 16,656 |
| Sep 2, 26 | Doyle John Q | sell | 16,656 |
| Sep 2, 26 | Doyle John Q | other | 16,656 |
| Aug 15, 26 | SCHAPIRO MORTON O | other | 218.9 |
| Aug 14, 26 | SCHAPIRO MORTON O | other | 473.39 |
| Aug 14, 26 | Anderson Anthony | other | 89.41 |
| Aug 14, 26 | HOPKINS DEBORAH C | other | 112.08 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MRSH coverage
Recent articles, reports, and earnings notes.

Marsh & McLennan (MRSH): Durable Compounder Despite Rich Valuation
Marsh & McLennan is executing well across broking and consulting, with 2025 revenue of $26.98B and Q1 2026 growth still running at 8%. The stock looks like a quality compounder, but valuation and leverage keep the upside measured.

Marsh & McLennan Companies, Inc. (MRSH) gains on deep earnings analysi
Marsh & McLennan Companies, Inc. (MRSH) gains after a steady Q1 that met expectations and reinforced the company’s resilience. This deep-dive earnings analysis examines margin durability, segment performance, guidance tone, and why investors rewarded disciplined execution over flash.

Marsh & McLennan (MRSH): Quality Compounder With Durable Growth
Marsh & McLennan stands out as a high-quality professional services compounder with strong margins, recurring fee-based revenue, and multiple growth levers. The stock looks more like a reasonable buy on weakness than a bargain-basement value play.
Want a deeper read on MRSH?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Marsh & McLennan: A Deep-Value Insurance Broker
seekingalpha.com · Sep 26
Marsh Appoints Birgit Boykin Chief People Officer of Oliver Wyman and Marsh Management Consulting
businesswire.com · Sep 25
Can Marsh Benefit From Changing Asset Owner Priorities?
zacks.com · Sep 22
Cash, infrastructure and emerging markets gain ground as large asset owners seek to manage volatility spikes, according to Marsh
businesswire.com · Sep 21
Marsh to Host Third Quarter Earnings Investor Call on October 15
businesswire.com · Sep 17
Insider Sale: CEO Dumps More Than 16,000 Shares of Financial Stock
fool.com · Sep 17
Can Marsh's AI Strategy Offset Softer Insurance Pricing?
zacks.com · Sep 17
Marsh Declares Quarterly Cash Dividend
businesswire.com · Sep 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed September 22, 2026 · Live quote · Not investment advice